REXAHN PHARMACEUTICALS, INC. (RNN) has 14 open-market insider trades by 9 insiders since 2009. The most active filer is Chang Ho Ahn, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Chang Ho Ahn | Dir | — | 5 | $4.0M | 2017-04-10 |
| Peter C. Brandt | Dir | — | 2 | $171K | 2011-09-09 |
| Tae Heum Jeong | CFO | — | 1 | $33K | 2015-01-12 |
| Douglas J. Swirsky | Pres | — | 1 | $32K | 2019-01-29 |
| Lisa Nolan | Chief Business Officer | — | 1 | $13K | 2019-02-28 |
| Ben Gil Price | Dir | — | 1 | $9K | 2019-01-29 |
| Charles Beever | Dir | — | 1 | $6K | 2019-01-31 |
| Richard Kivel | Dir | — | 1 | $3K | 2011-10-03 |
| David M. McIntosh | Dir | — | 1 | $2K | 2014-04-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Charles Beever | Director | Buy | $6K | 2019-01-31 |
| Lisa Nolan | Chief Business Officer | Buy | $13K | 2019-01-30 |
| Douglas J. Swirsky | President | Buy | $32K | 2019-01-29 |
| Ben Gil Price | Director | Buy | $9K | 2019-01-29 |
| Chang Ho Ahn | Director | Sell | $175K | 2017-04-10 |
| Chang Ho Ahn | Director | Sell | $287K | 2015-01-08 |
Companies that share insiders with RNN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Tae Heum Jeong | CFO | Sell | $290K | 2015-01-08 |
| Chang Ho Ahn | Director | Sell | $135K | 2014-06-12 |
| Tae Heum Jeong | CFO | Sell | $33K | 2013-09-09 |
| Richard Kivel | Director | Buy | $3K | 2011-10-03 |
| Peter C. Brandt | Director | Buy | $147K | 2011-09-08 |
| Peter C. Brandt | Director | Buy | $24K | 2011-09-06 |
| Chang Ho Ahn | Chairman & 10% | Buy | $1.3M | 2011-05-18 |
| Chang Ho Ahn | Chairman & 10% | Buy | $391K | 2011-04-01 |
| David M. McIntosh | Director | Buy | $2K | 2009-07-30 |